@article{Stock_S-2022_93969,
title = {Early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection: a national population-based matched cohort study},
author = {Stock, S. and Calvert, C. and Carruthers, J. and Denny, C. and Donaghy, J. and Hillman, S. and Hopcroft, L. and Hopkins, L. and Goulding, A. and Lindsay, L. and McLaughlin, T. and Moore, E. and Pan, J. and Taylor, J. and Almaghrabi, F. and Auyeung, B. and Bhaskaran, K. and Gibbons, C. and Katikireddi, S. and McCowan, C. and Murray, J. and O'Leary, M. and Ritchie, L. and Shah, S. and Simpson, C. and Robertson, C. and Sheikh, A. and Wood, R.},
month = {aug},
year = {2022},
abstract = {COVID-19 vaccination is effective in reducing the risk of severe SARS-CoV-2 infection in pregnant women,1,2but high levels of vaccine hesitancy remain in pregnant populations. In England and Scotland, 59.5% and 63.0%, respectively of women giving birth in January 2022 had received at least one prior dose of COVID-19 vaccination at any point, which was considerably lower than the coverage seen among the general population of reproductive age women at that time.3–5},
journal = {Nature Portfolio},
publisher = {Research Square},
url = {https://doi.org/10.21203/rs.3.rs-1955486/v1},
}
